Tokyo Tape
Sign in
← Astellas Pharma

Annual report

4503.TEDINET S100SMI3
Period2022-04-01 → 2023-03-31
Filed2024-01-16
StandardIFRS
ConsolidatedYes
Data checks21 of 21 passed

Amends S100R0I6. Amended by S100SMT5 (2024-01-16).

Key figures · 157
MetricValuePeriodScopeSource row
Revenue¥1.52T2022-04-01 → 2023-03-31Cons.Revenue IFRS
Revenue¥1.30T2021-04-01 → 2022-03-31Cons.Revenue IFRS
Revenue¥1.25T2020-04-01 → 2021-03-31dCons.Revenue IFRS (5-year summary)
Revenue¥1.30T2019-04-01 → 2020-03-31dCons.Revenue IFRS (5-year summary)
Revenue¥1.31T2018-04-01 → 2019-03-31dCons.Revenue IFRS (5-year summary)
Operating income¥133.0bn2022-04-01 → 2023-03-31Cons.Operating profit loss IFRS
Operating income¥155.7bn2021-04-01 → 2022-03-31Cons.Operating profit loss IFRS
Profit before tax¥132.4bn2022-04-01 → 2023-03-31Cons.Profit loss before tax IFRS
Profit before tax¥156.9bn2021-04-01 → 2022-03-31Cons.Profit loss before tax IFRS
Profit before tax¥145.3bn2020-04-01 → 2021-03-31dCons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥245.3bn2019-04-01 → 2020-03-31dCons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥249.0bn2018-04-01 → 2019-03-31dCons.Profit loss before tax IFRS (5-year summary)
Net income (owners)¥98.7bn2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥124.1bn2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥120.6bn2020-04-01 → 2021-03-31dCons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥195.4bn2019-04-01 → 2020-03-31dCons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥222.3bn2018-04-01 → 2019-03-31dCons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income¥98.7bn2022-04-01 → 2023-03-31Cons.Profit loss IFRS
Net income¥124.1bn2021-04-01 → 2022-03-31Cons.Profit loss IFRS
Total assets¥2.46Tat 2023-03-31Cons.Assets IFRS
Total assets¥2.33Tat 2022-03-31Cons.Assets IFRS
Total assets¥2.27Tat 2021-03-31dCons.Total assets IFRS (5-year summary)
Total assets¥2.32Tat 2020-03-31dCons.Total assets IFRS (5-year summary)
Total assets¥1.90Tat 2019-03-31dCons.Total assets IFRS (5-year summary)
Total liabilities¥948.6bnat 2023-03-31Cons.Liabilities IFRS
Total liabilities¥872.1bnat 2022-03-31Cons.Liabilities IFRS
Net assets / equity¥1.51Tat 2023-03-31Cons.Equity IFRS
Net assets / equity¥1.46Tat 2022-03-31Cons.Equity IFRS
Net assets / equity¥1.39Tat 2021-03-31dCons.Equity IFRS
Equity (owners)¥1.51Tat 2023-03-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥1.46Tat 2022-03-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥1.39Tat 2021-03-31dCons.Equity attributable to owners of parent IFRS (5-year summary)
Equity (owners)¥1.29Tat 2020-03-31dCons.Equity attributable to owners of parent IFRS (5-year summary)
Equity (owners)¥1.26Tat 2019-03-31dCons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥376.8bnat 2023-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥316.0bnat 2022-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥326.1bnat 2021-03-31dCons.Cash and cash equivalents IFRS
Cash & equivalents¥318.4bnat 2020-03-31dCons.Cash and cash equivalents IFRS (5-year summary)
Cash & equivalents¥311.1bnat 2019-03-31dCons.Cash and cash equivalents IFRS (5-year summary)
Operating cash flow¥327.8bn2022-04-01 → 2023-03-31Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥257.4bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥306.8bn2020-04-01 → 2021-03-31dCons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥222.0bn2019-04-01 → 2020-03-31dCons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥258.6bn2018-04-01 → 2019-03-31dCons.Cash flows from used in operating activities IFRS (5-year summary)
Investing cash flow−¥84.5bn2022-04-01 → 2023-03-31Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥62.4bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥81.9bn2020-04-01 → 2021-03-31dCons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥389.8bn2019-04-01 → 2020-03-31dCons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥41.8bn2018-04-01 → 2019-03-31dCons.Cash flows from used in investing activities IFRS (5-year summary)
Financing cash flow−¥195.6bn2022-04-01 → 2023-03-31Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥216.3bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥229.5bn2020-04-01 → 2021-03-31dCons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow¥181.1bn2019-04-01 → 2020-03-31dCons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥233.7bn2018-04-01 → 2019-03-31dCons.Cash flows from used in financing activities IFRS (5-year summary)
EPS (basic)¥54.242022-04-01 → 2023-03-31Cons.Basic earnings loss per share IFRS
EPS (basic)¥67.082021-04-01 → 2022-03-31Cons.Basic earnings loss per share IFRS
EPS (basic)¥64.932020-04-01 → 2021-03-31dCons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥104.152019-04-01 → 2020-03-31dCons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥115.052018-04-01 → 2019-03-31dCons.Basic earnings loss per share IFRS (5-year summary)
EPS (diluted)¥54.092022-04-01 → 2023-03-31Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥67.052021-04-01 → 2022-03-31Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥64.92020-04-01 → 2021-03-31dCons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥104.082019-04-01 → 2020-03-31dCons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥114.942018-04-01 → 2019-03-31dCons.Diluted earnings loss per share IFRS (5-year summary)
Net assets per share¥839.26at 2023-03-31Cons.Equity to asset ratio IFRS (5-year summary)
Net assets per share¥799.26at 2022-03-31Cons.Equity to asset ratio IFRS (5-year summary)
Net assets per share¥748.03at 2021-03-31dCons.Equity to asset ratio IFRS (5-year summary)
Net assets per share¥694.03at 2020-03-31dCons.Equity to asset ratio IFRS (5-year summary)
Net assets per share¥667.29at 2019-03-31dCons.Equity to asset ratio IFRS (5-year summary)
Equity ratio61.4%at 2023-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio62.6%at 2022-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio61.0%at 2021-03-31dCons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio55.7%at 2020-03-31dCons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio66.3%at 2019-03-31dCons.Ratio of owners equity to gross assets IFRS (5-year summary)
ROE6.7%2022-04-01 → 2023-03-31Cons.Rate of return on equity IFRS (5-year summary)
ROE8.7%2021-04-01 → 2022-03-31Cons.Rate of return on equity IFRS (5-year summary)
ROE9.0%2020-04-01 → 2021-03-31dCons.Rate of return on equity IFRS (5-year summary)
ROE15.3%2019-04-01 → 2020-03-31dCons.Rate of return on equity IFRS (5-year summary)
ROE17.6%2018-04-01 → 2019-03-31dCons.Rate of return on equity IFRS (5-year summary)
Employees14,484at 2023-03-31Cons.Number of employees
Employees14,522at 2022-03-31Cons.Number of employees
Employees15,455at 2021-03-31dCons.Number of employees
Employees15,883at 2020-03-31dCons.Number of employees
Employees16,243at 2019-03-31dCons.Number of employees
Revenue¥613.6bn2022-04-01 → 2023-03-31StandaloneNet sales
Revenue¥542.6bn2021-04-01 → 2022-03-31StandaloneNet sales
Revenue¥545.6bn2020-04-01 → 2021-03-31dStandaloneNet sales (5-year summary)
Revenue¥600.6bn2019-04-01 → 2020-03-31dStandaloneNet sales (5-year summary)
Revenue¥607.3bn2018-04-01 → 2019-03-31dStandaloneNet sales (5-year summary)
Operating income¥130.6bn2022-04-01 → 2023-03-31StandaloneOperating income
Operating income¥105.9bn2021-04-01 → 2022-03-31StandaloneOperating income
Ordinary income¥338.2bn2022-04-01 → 2023-03-31StandaloneOrdinary income
Ordinary income¥270.5bn2021-04-01 → 2022-03-31StandaloneOrdinary income
Ordinary income¥223.4bn2020-04-01 → 2021-03-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income¥293.2bn2019-04-01 → 2020-03-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income¥209.7bn2018-04-01 → 2019-03-31dStandaloneOrdinary income loss (5-year summary)
Profit before tax¥348.1bn2022-04-01 → 2023-03-31StandaloneIncome before income taxes
Profit before tax¥254.1bn2021-04-01 → 2022-03-31StandaloneIncome before income taxes
Net income¥314.2bn2022-04-01 → 2023-03-31StandaloneProfit loss
Net income¥225.1bn2021-04-01 → 2022-03-31StandaloneProfit loss
Net income¥193.1bn2020-04-01 → 2021-03-31dStandaloneNet income loss (5-year summary)
Net income¥240.6bn2019-04-01 → 2020-03-31dStandaloneNet income loss (5-year summary)
Net income¥178.7bn2018-04-01 → 2019-03-31dStandaloneNet income loss (5-year summary)
Total assets¥1.49Tat 2023-03-31StandaloneAssets
Total assets¥1.39Tat 2022-03-31StandaloneAssets
Total assets¥1.35Tat 2021-03-31dStandaloneTotal assets (5-year summary)
Total assets¥1.33Tat 2020-03-31dStandaloneTotal assets (5-year summary)
Total assets¥1.23Tat 2019-03-31dStandaloneTotal assets (5-year summary)
Total liabilities¥466.1bnat 2023-03-31StandaloneLiabilities
Total liabilities¥514.9bnat 2022-03-31StandaloneLiabilities
Net assets / equity¥1.02Tat 2023-03-31StandaloneNet assets
Net assets / equity¥873.6bnat 2022-03-31StandaloneNet assets
Net assets / equity¥787.7bnat 2021-03-31dStandaloneNet assets
Net assets / equity¥671.6bnat 2020-03-31dStandaloneNet assets (5-year summary)
Net assets / equity¥565.6bnat 2019-03-31dStandaloneNet assets (5-year summary)
Cash and deposits¥217.0bnat 2023-03-31StandaloneCash and deposits
Cash and deposits¥184.0bnat 2022-03-31StandaloneCash and deposits
EPS (basic)¥172.642022-04-01 → 2023-03-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥121.692021-04-01 → 2022-03-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥103.952020-04-01 → 2021-03-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥128.262019-04-01 → 2020-03-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥92.492018-04-01 → 2019-03-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (diluted)¥172.572022-04-01 → 2023-03-31StandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥121.632021-04-01 → 2022-03-31StandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥103.892020-04-01 → 2021-03-31dStandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥128.172019-04-01 → 2020-03-31dStandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥92.42018-04-01 → 2019-03-31dStandaloneDiluted earnings per share (5-year summary)
Dividend per share¥602022-04-01 → 2023-03-31StandaloneDividend paid per share (5-year summary)
Dividend per share¥502021-04-01 → 2022-03-31StandaloneDividend paid per share (5-year summary)
Dividend per share¥422020-04-01 → 2021-03-31dStandaloneDividend paid per share (5-year summary)
Dividend per share¥402019-04-01 → 2020-03-31dStandaloneDividend paid per share (5-year summary)
Dividend per share¥382018-04-01 → 2019-03-31dStandaloneDividend paid per share (5-year summary)
Net assets per share¥568.97at 2023-03-31StandaloneNet assets per share (5-year summary)
Net assets per share¥477.81at 2022-03-31StandaloneNet assets per share (5-year summary)
Net assets per share¥424.69at 2021-03-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥361.08at 2020-03-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥299.34at 2019-03-31dStandaloneNet assets per share (5-year summary)
Equity ratio68.7%at 2023-03-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio62.9%at 2022-03-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio58.3%at 2021-03-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio50.4%at 2020-03-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio45.8%at 2019-03-31dStandaloneEquity to asset ratio (5-year summary)
ROE33.2%2022-04-01 → 2023-03-31StandaloneRate of return on equity (5-year summary)
ROE27.1%2021-04-01 → 2022-03-31StandaloneRate of return on equity (5-year summary)
ROE26.5%2020-04-01 → 2021-03-31dStandaloneRate of return on equity (5-year summary)
ROE39.0%2019-04-01 → 2020-03-31dStandaloneRate of return on equity (5-year summary)
ROE30.4%2018-04-01 → 2019-03-31dStandaloneRate of return on equity (5-year summary)
Shares issued1,809,663,000at 2023-03-31StandaloneTotal number of issued shares (5-year summary)
Shares issued1,835,852,000at 2022-03-31StandaloneTotal number of issued shares (5-year summary)
Shares issued1,861,787,000at 2021-03-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued1,861,787,000at 2020-03-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued1,979,823,000at 2019-03-31dStandaloneTotal number of issued shares (5-year summary)
Employees4,867at 2023-03-31StandaloneNumber of employees
Employees3,943at 2022-03-31StandaloneNumber of employees
Employees4,647at 2021-03-31dStandaloneNumber of employees
Employees4,560at 2020-03-31dStandaloneNumber of employees
Employees5,034at 2019-03-31dStandaloneNumber of employees

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 2
SegmentItemPeriodValue
Pharmaceuticalreportable segmentemployeesat 2023-03-3114484 pure
Pharmaceuticalreportable segmentemployeesat 2023-03-314867 pure

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 1,666
ItemContextValueUnit
Retirement of treasury stockCurrentYearDuration_NonConsolidatedMember_ValuationDifferenceOnAvailableForSaleSecuritiesMember－JPY
Retirement of treasury stockCurrentYearDuration_NonConsolidatedMember_ValuationAndTranslationAdjustmentsMember－JPY
Retirement of treasury stockCurrentYearDuration_NonConsolidatedMember_SubscriptionRightsToSharesMember－JPY
Retirement of treasury stockCurrentYearDuration_NonConsolidatedMember－JPY
Net changes of items other than shareholders equityCurrentYearDuration_NonConsolidatedMember_TreasuryStockMember－JPY
Net changes of items other than shareholders equityCurrentYearDuration_NonConsolidatedMember_ShareholdersEquityMember－JPY
Net changes of items other than shareholders equityCurrentYearDuration_NonConsolidatedMember_ValuationDifferenceOnAvailableForSaleSecuritiesMember-5094000000JPY
Net changes of items other than shareholders equityCurrentYearDuration_NonConsolidatedMember_ValuationAndTranslationAdjustmentsMember-5094000000JPY
Net changes of items other than shareholders equityCurrentYearDuration_NonConsolidatedMember_SubscriptionRightsToSharesMember-94000000JPY
Net changes of items other than shareholders equityCurrentYearDuration_NonConsolidatedMember-5188000000JPY
Total changes of items during the periodCurrentYearDuration_NonConsolidatedMember_TreasuryStockMember-11190000000JPY
Total changes of items during the periodCurrentYearDuration_NonConsolidatedMember_ShareholdersEquityMember154400000000JPY
Total changes of items during the periodCurrentYearDuration_NonConsolidatedMember_ValuationDifferenceOnAvailableForSaleSecuritiesMember-5094000000JPY
Total changes of items during the periodCurrentYearDuration_NonConsolidatedMember_ValuationAndTranslationAdjustmentsMember-5094000000JPY
Total changes of items during the periodCurrentYearDuration_NonConsolidatedMember_SubscriptionRightsToSharesMember-94000000JPY
Total changes of items during the periodCurrentYearDuration_NonConsolidatedMember149212000000JPY
Net assetsCurrentYearInstant_NonConsolidatedMember_TreasuryStockMember-25123000000JPY
Net assetsCurrentYearInstant_NonConsolidatedMember_ShareholdersEquityMember1012102000000JPY
Net assetsCurrentYearInstant_NonConsolidatedMember_ValuationDifferenceOnAvailableForSaleSecuritiesMember10196000000JPY
Net assetsCurrentYearInstant_NonConsolidatedMember_ValuationAndTranslationAdjustmentsMember10196000000JPY
Net assetsCurrentYearInstant_NonConsolidatedMember_SubscriptionRightsToSharesMember536000000JPY
Net assetsCurrentYearInstant_NonConsolidatedMember1022834000000JPY
Salaries allowances and bonuses sgaPrior1YearDuration_NonConsolidatedMember37910000000JPY
Salaries allowances and bonuses sgaCurrentYearDuration_NonConsolidatedMember32492000000JPY
Research and development expenses sgaPrior1YearDuration_NonConsolidatedMember146183000000JPY
Research and development expenses sgaCurrentYearDuration_NonConsolidatedMember156410000000JPY
License fee sgaPrior1YearDuration_NonConsolidatedMember73727000000JPY
License fee sgaCurrentYearDuration_NonConsolidatedMember95017000000JPY
Document title cover pageFilingDateInstant
Original text (Japanese)有価証券報告書 (2024年１月16日付け訂正報告書の添付インライン XBRL）
Clause of stipulation cover pageFilingDateInstant
Original text (Japanese)金融商品取引法第24条第１項
Place of filing cover pageFilingDateInstant
Original text (Japanese)関東財務局長
Filing date cover pageFilingDateInstant2023-06-22
Fiscal year cover pageFilingDateInstant
Original text (Japanese)第18期 (自　2022年４月１日　至　2023年３月31日)
Company name cover pageFilingDateInstant
Original text (Japanese)アステラス製薬株式会社
Company name in english cover pageFilingDateInstantAstellas Pharma Inc.
Title and name of representative cover pageFilingDateInstant
Original text (Japanese)代表取締役社長　岡村　直樹
Address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)東京都中央区日本橋本町二丁目５番１号
Telephone number address of registered headquarter cover pageFilingDateInstant03 (3244) 3000
Name of contact person address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)コーポレートアカウンティング・グローバルビジネスサービスコーポレートアカウンティング　グループリーダー　藤田　康博
Nearest place of contact cover pageFilingDateInstant
Original text (Japanese)東京都中央区日本橋本町二丁目５番１号
Telephone number nearest place of contact cover pageFilingDateInstant03 (3244) 3000
Name of contact person nearest place of contact cover pageFilingDateInstant
Original text (Japanese)コーポレートアカウンティング・グローバルビジネスサービスコーポレートアカウンティング　グループリーダー　藤田　康博
Place for public inspection cover page (text)FilingDateInstantText · Plus
Edinet codeFilingDateInstantE00920
Fund codeFilingDateInstant－
Security codeFilingDateInstant45030
Filer name in japaneseFilingDateInstant
Original text (Japanese)アステラス製薬株式会社
Filer name in englishFilingDateInstantAstellas Pharma Inc.
Fund name in japaneseFilingDateInstant－
Fund name in englishFilingDateInstant－

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 21 of 21 passed
balance sheet identityconsolidated 2022-03-31pass
balance sheet identityconsolidated 2023-03-31pass
balance sheet identitynon_consolidated 2022-03-31pass
balance sheet identitynon_consolidated 2023-03-31pass
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2021-03-31pass
statement vs summary · net assetsnon_consolidated 2022-03-31pass
statement vs summary · net assetsnon_consolidated 2023-03-31pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2022-03-31pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2023-03-31pass
statement vs summary · operating cash flowconsolidated 2021-04-01/2022-03-31pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2023-03-31pass
statement vs summary · revenueconsolidated 2021-04-01/2022-03-31pass
statement vs summary · revenueconsolidated 2022-04-01/2023-03-31pass
statement vs summary · revenuenon_consolidated 2021-04-01/2022-03-31pass
statement vs summary · revenuenon_consolidated 2022-04-01/2023-03-31pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsnon_consolidated 2022-03-31pass
statement vs summary · total assetsnon_consolidated 2023-03-31pass